TMEM184C
geneOn this page
Also known as FLJ10846SLC51C3
Summary
TMEM184C (transmembrane protein 184C, HGNC:25587) is a protein-coding gene on chromosome 4q31.23, encoding Transmembrane protein 184C (Q9NVA4). Possible tumor suppressor which may play a role in cell growth.
Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be active in membrane.
Source: NCBI Gene 55751 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 46 total
- MANE Select transcript:
NM_018241
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25587 |
| Approved symbol | TMEM184C |
| Name | transmembrane protein 184C |
| Location | 4q31.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10846, SLC51C3 |
| Ensembl gene | ENSG00000164168 |
| Ensembl biotype | protein_coding |
| OMIM | 613937 |
| Entrez | 55751 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000296582, ENST00000505999, ENST00000506826, ENST00000508208, ENST00000880769
RefSeq mRNA: 1 — MANE Select: NM_018241
NM_018241
CCDS: CCDS3770
Canonical transcript exons
ENST00000296582 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001082022 | 147623834 | 147623964 |
| ENSE00001082023 | 147634169 | 147636721 |
| ENSE00001082024 | 147631393 | 147631505 |
| ENSE00001082025 | 147632903 | 147633002 |
| ENSE00001082026 | 147624062 | 147624098 |
| ENSE00001082027 | 147628361 | 147628435 |
| ENSE00001082028 | 147629599 | 147629692 |
| ENSE00001082029 | 147624804 | 147625009 |
| ENSE00002064092 | 147617397 | 147618079 |
| ENSE00003635781 | 147633765 | 147633936 |
Expression profiles
Bgee: expression breadth ubiquitous, 259 present calls, max score 95.20.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.4916 / max 99.0617, expressed in 1804 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 49935 | 14.1120 | 1800 |
| 49936 | 1.1802 | 718 |
| 49937 | 0.1340 | 35 |
| 49938 | 0.0653 | 23 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 95.20 | silver quality |
| endothelial cell | CL:0000115 | 94.80 | silver quality |
| hair follicle | UBERON:0002073 | 94.37 | silver quality |
| buccal mucosa cell | CL:0002336 | 94.25 | gold quality |
| mammary duct | UBERON:0001765 | 92.39 | silver quality |
| adrenal tissue | UBERON:0018303 | 92.09 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.76 | silver quality |
| epithelium of mammary gland | UBERON:0003244 | 91.63 | silver quality |
| calcaneal tendon | UBERON:0003701 | 91.37 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 91.03 | silver quality |
| stromal cell of endometrium | CL:0002255 | 90.85 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 90.77 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 90.57 | gold quality |
| colonic mucosa | UBERON:0000317 | 90.37 | gold quality |
| biceps brachii | UBERON:0001507 | 90.34 | silver quality |
| CA1 field of hippocampus | UBERON:0003881 | 90.25 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 90.19 | gold quality |
| rectum | UBERON:0001052 | 89.13 | gold quality |
| oviduct epithelium | UBERON:0004804 | 88.90 | gold quality |
| oocyte | CL:0000023 | 88.72 | silver quality |
| corpus callosum | UBERON:0002336 | 88.69 | gold quality |
| islet of Langerhans | UBERON:0000006 | 88.61 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 88.59 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 88.57 | gold quality |
| mammary gland | UBERON:0001911 | 88.53 | gold quality |
| placenta | UBERON:0001987 | 88.53 | gold quality |
| thyroid gland | UBERON:0002046 | 88.45 | gold quality |
| seminal vesicle | UBERON:0000998 | 88.31 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 88.21 | gold quality |
| secondary oocyte | CL:0000655 | 88.18 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.16 |
| E-MTAB-6386 | no | 109.85 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
64 targeting TMEM184C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
Literature-anchored findings (GeneRIF, showing 1)
- Recently, by cDNA microarray anal., we identified transmembrane protein 34 (TMEM34) that down-regulated in anaplastic thyroid cancer cell lines as compared to normal thyroid tissues. Transfection of TMEM34 into KTA2 cells led to inhibition of cell growth (PMID:17072649)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem184c | ENSDARG00000078789 |
| mus_musculus | Tmem184c | ENSMUSG00000031617 |
| rattus_norvegicus | Tmem184c | ENSRNOG00000012860 |
| drosophila_melanogaster | CG5850 | FBGN0032172 |
Paralogs (3): SLC51A (ENSG00000163959), TMEM184A (ENSG00000164855), TMEM184B (ENSG00000198792)
Protein
Protein identifiers
Transmembrane protein 184C — Q9NVA4 (reviewed: Q9NVA4)
Alternative names: Transmembrane protein 34
All UniProt accessions (3): A0A0C4DGC8, Q9NVA4, H0Y8I5
UniProt curated annotations — full annotation on UniProt →
Function. Possible tumor suppressor which may play a role in cell growth.
Subcellular location. Membrane.
Tissue specificity. Widely expressed with higher expression in lung, kidney, spleen, pancreas, thymus, prostate, testis, ovary, small intestine and thyroid.
Similarity. Belongs to the TMEM184 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NVA4-1 | 1 | yes |
| Q9NVA4-2 | 2 |
RefSeq proteins (1): NP_060711* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005178 | Ostalpha/TMEM184C | Family |
Pfam: PF03619
UniProt features (18 total): transmembrane region 7, sequence conflict 4, compositionally biased region 3, chain 1, modified residue 1, splice variant 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NVA4-F1 | 72.08 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 422
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 93 (showing top):
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN, GOBP_TRANSMEMBRANE_TRANSPORT, CAIRO_LIVER_DEVELOPMENT_UP, RUTELLA_RESPONSE_TO_HGF_UP, STEIN_ESRRA_TARGETS_UP, GOMF_TRANSPORTER_ACTIVITY, RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP, GCM_RAB10, GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP, CEBPZ_TARGET_GENES, DIDO1_TARGET_GENES, ELF2_TARGET_GENES, HDAC4_TARGET_GENES, ZNF350_TARGET_GENES
GO Biological Process (1): transmembrane transport (GO:0055085)
GO Molecular Function (1): transmembrane transporter activity (GO:0022857)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 1 |
| cellular process | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
622 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM184C | PRMT9 | Q6P2P2 | 716 |
| TMEM184C | FAM204A | Q9H8W3 | 618 |
| TMEM184C | EDNRA | P25101 | 530 |
| TMEM184C | ACBD6 | Q9BR61 | 512 |
| TMEM184C | HSF2 | Q03933 | 505 |
| TMEM184C | ZCCHC9 | Q8N567 | 476 |
| TMEM184C | FAM13B | Q9NYF5 | 469 |
| TMEM184C | TMEM207 | Q6UWW9 | 465 |
| TMEM184C | OR7E24 | Q6IFN5 | 460 |
| TMEM184C | RAB11FIP2 | Q7L804 | 443 |
| TMEM184C | PNISR | Q8TF01 | 435 |
| TMEM184C | KIF6 | Q6ZMV9 | 427 |
| TMEM184C | TMEM214 | Q6NUQ4 | 414 |
| TMEM184C | SLC35A4 | Q96G79 | 411 |
| TMEM184C | COL23A1 | Q86Y22 | 400 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SGK1 | TMEM184C | psi-mi:“MI:0915”(physical association) | 0.370 |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| E5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| Npc1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| LAMP1 | DST | psi-mi:“MI:0914”(association) | 0.350 |
| LAMTOR2 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPRE1 | SCAMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| POLR1D | BDP1 | psi-mi:“MI:0914”(association) | 0.350 |
| STX7 | SCAMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| TNFRSF10C | PLPP3 | psi-mi:“MI:0914”(association) | 0.350 |
| TCTN3 | TMEM120B | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (22): TMEM184C (Proximity Label-MS), TMEM184C (Synthetic Lethality), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Proximity Label-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Affinity Capture-MS), TMEM184C (Cross-Linking-MS (XL-MS)), TMEM184C (Affinity Capture-MS), TMEM184C (Co-fractionation)
ESM2 similar proteins: A0JNC1, A0PK00, A1L2R7, A2BIE7, A3KNK1, A6QPF8, A7XZ53, A8DZH4, D3ZEH5, O35052, O95427, P98191, Q05B45, Q0VFK3, Q17QL9, Q1LY80, Q28CY9, Q3TA38, Q5BL21, Q5EAX9, Q5EAY8, Q5FWV6, Q5HZE2, Q5RET6, Q5U239, Q5ZMP3, Q63ZG0, Q68EY2, Q6DD44, Q6DE21, Q6ZMG9, Q7ZUA6, Q8BXA5, Q8C172, Q8C1E7, Q8CIF6, Q8NBJ9, Q8WVP7, Q91XU8, Q92903
Diamond homologs: A2VDL9, Q09906, Q17QL9, Q1RMW2, Q28CV2, Q3TPR7, Q3UFJ6, Q4QQS1, Q54PI4, Q54WM0, Q5BPZ5, Q5RET6, Q5ZMP3, Q6GQE1, Q6ZMB5, Q75JN3, Q810F5, Q8BG09, Q9NVA4, Q9Y519, F4JTN2, Q94CA0, P36142
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2592 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:147623828:CTTAA:C | acceptor_loss | 1.0000 |
| 4:147623829:TTAA:T | acceptor_loss | 1.0000 |
| 4:147623832:A:G | acceptor_gain | 1.0000 |
| 4:147623833:G:C | acceptor_loss | 1.0000 |
| 4:147623962:AAGGT:A | donor_loss | 1.0000 |
| 4:147623964:GGTA:G | donor_loss | 1.0000 |
| 4:147624057:AATAG:A | acceptor_gain | 1.0000 |
| 4:147624094:ATAGT:A | donor_gain | 1.0000 |
| 4:147624095:TAGT:T | donor_gain | 1.0000 |
| 4:147624097:GT:G | donor_gain | 1.0000 |
| 4:147624099:G:GG | donor_gain | 1.0000 |
| 4:147624800:ATAGT:A | acceptor_gain | 1.0000 |
| 4:147624802:A:AG | acceptor_gain | 1.0000 |
| 4:147624802:AGT:A | acceptor_gain | 1.0000 |
| 4:147624802:AGTG:A | acceptor_gain | 1.0000 |
| 4:147624803:G:GG | acceptor_gain | 1.0000 |
| 4:147624803:GT:G | acceptor_gain | 1.0000 |
| 4:147624803:GTG:G | acceptor_gain | 1.0000 |
| 4:147624803:GTGG:G | acceptor_gain | 1.0000 |
| 4:147625005:GGAGA:G | donor_gain | 1.0000 |
| 4:147625006:GAGAG:G | donor_gain | 1.0000 |
| 4:147625008:GA:G | donor_gain | 1.0000 |
| 4:147625010:G:GG | donor_gain | 1.0000 |
| 4:147628359:A:AG | acceptor_gain | 1.0000 |
| 4:147628360:G:GG | acceptor_gain | 1.0000 |
| 4:147628360:GA:G | acceptor_gain | 1.0000 |
| 4:147628360:GAGT:G | acceptor_gain | 1.0000 |
| 4:147628360:GAGTA:G | acceptor_gain | 1.0000 |
| 4:147628431:GCTTT:G | donor_gain | 1.0000 |
| 4:147628433:TTT:T | donor_gain | 1.0000 |
AlphaMissense
2851 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:147623950:A:C | Q80H | 0.999 |
| 4:147623950:A:T | Q80H | 0.999 |
| 4:147624069:T:A | W88R | 0.999 |
| 4:147624069:T:C | W88R | 0.999 |
| 4:147624087:A:C | S94R | 0.999 |
| 4:147624089:T:A | S94R | 0.999 |
| 4:147624089:T:G | S94R | 0.999 |
| 4:147624854:A:C | R114S | 0.999 |
| 4:147624854:A:T | R114S | 0.999 |
| 4:147631409:T:C | L228P | 0.999 |
| 4:147631501:T:C | F259L | 0.999 |
| 4:147631503:T:A | F259L | 0.999 |
| 4:147631503:T:G | F259L | 0.999 |
| 4:147633788:G:A | M301I | 0.999 |
| 4:147633788:G:C | M301I | 0.999 |
| 4:147633788:G:T | M301I | 0.999 |
| 4:147633819:T:C | F312L | 0.999 |
| 4:147633821:C:A | F312L | 0.999 |
| 4:147633821:C:G | F312L | 0.999 |
| 4:147623964:G:T | R85M | 0.998 |
| 4:147624073:T:C | M89T | 0.998 |
| 4:147624073:T:G | M89R | 0.998 |
| 4:147624804:T:A | W98R | 0.998 |
| 4:147624804:T:C | W98R | 0.998 |
| 4:147624853:G:C | R114T | 0.998 |
| 4:147624853:G:T | R114I | 0.998 |
| 4:147624865:A:T | E118V | 0.998 |
| 4:147624898:T:C | L129P | 0.998 |
| 4:147628386:G:C | G175R | 0.998 |
| 4:147628387:G:A | G175D | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000551635 (4:147632078 CAGG>C), RS1000622543 (4:147630103 T>C), RS1000883621 (4:147636543 G>T), RS1000899940 (4:147632401 A>G), RS1000944682 (4:147630428 A>T), RS1001093606 (4:147618709 C>A,T), RS1001667848 (4:147631967 G>A), RS1001705919 (4:147635644 T>C,G), RS1001722009 (4:147631787 A>G), RS1002111023 (4:147621948 T>C), RS1002222701 (4:147629216 C>T), RS1002354024 (4:147621485 A>T), RS1002494302 (4:147629944 T>G), RS1002555319 (4:147635117 CG>C), RS1002858881 (4:147621196 T>C)
Disease associations
OMIM: gene MIM:613937 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002960_3 | Frontotemporal dementia | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Cadmium Chloride | increases abundance, increases palmitoylation, decreases expression, decreases reaction | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| 2-bromopalmitate | decreases reaction, increases abundance, increases palmitoylation | 1 |
| N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Cadmium | decreases reaction, increases abundance, increases palmitoylation | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Lead | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
| Zinc Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): frontotemporal dementia